Haemonetics Corp. (HAE) Chairman of the Board Brad Nutter sells 173,128 Shares

Chairman of the Board of Haemonetics Corp. (HAE, Financial) Brad Nutter sells 173,128 shares of HAE on 03/24/2010 at an average price of $57 a share.

Haemonetics Corp. has a market cap of $1.43 billion; its shares were traded at around $56.73 with a P/E ratio of 20.7 and P/S ratio of 2.4. Haemonetics Corp. had an annual average earning growth of 10.6% over the past 10 years. GuruFocus rated Haemonetics Corp. the business predictability rank of 5-star.

HAE is in the portfolios of Jim Simons of Renaissance Technologies LLC, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Steven Cohen of SAC Capital Advisors.

CEO Recent Trades:

  • Sell:: President & CEO Brian Concannon sold 260 shares of HAE stock on 10/27/2009 at the average price of 53.86, the price of the stock has increased by 5.33% since.



CFO Recent Trades:

  • Sell:: CFO & Vice President of Christopher J Lindop sold 107 shares of HAE stock on 10/26/2009 at the average price of 54.52, the price of the stock has increased by 4.05% since.



Directors and Officers Recent Trades:

  • Sell:: Director Lawrence C Best sold 50,000 shares of HAE stock on 02/18/2010 at the average price of 53.42, the price of the stock has increased by 6.2% since.

  • Sell:: Director Lawrence C Best sold 50,000 shares of HAE stock on 02/17/2010 at the average price of 53.57, the price of the stock has increased by 5.9% since.

  • Sell:: Chief Marketing Officer Peter M Allen sold 2,200 shares of HAE stock on 02/10/2010 at the average price of 52.56, the price of the stock has increased by 7.93% since.

  • Sell:: VP, Corporate Affairs Alicia R Lopez sold 143 shares of HAE stock on 10/26/2009 at the average price of 54.38, the price of the stock has increased by 4.32% since.

  • Sell:: VP Finance Susan M Hanlon sold 145 shares of HAE stock on 10/26/2009 at the average price of 54.38, the price of the stock has increased by 4.32% since.